MTL-CEBPA

N/A

Report date: 2024/11/01 15:52:26

Base Information

Drug NameMTL-CEBPA
Drug Alias NameMTL-CEBPA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionCCAAT/enhancer-binding protein alpha inducers
TargetsCCAAT/enhancer-binding protein alpha
Therapy Area/IndicationsSolid tumoursLiver NeoplasmsCarcinoma, Hepatocellular +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeTaiwan +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical CenterMarina BiotechUc San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesMina Alpha Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLiver NeoplasmsCarcinoma, Hepatocellular +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A